Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

MAR 07, 2013 - Benzinga

A Must Read - Share

UPDATE: Morgan Stanley Raises PT to $31 on Pfizer on Pipeline Potential in Second Half of 2013

Morgan Stanley maintained Pfizer (NYSE: PFE) with a Overweight and raised the price target from $27.00 to $31.00. Morgan Stanley noted, "Pfizer's FCF yield is attractive at 8%. Raising PT from $27 to $31 based upon greater long-term pipeline contribution and thus more optimistic DCF (changed terminal growth from -3% to -2%).

Tags: UPDATE: Morgan Stanley Raises PT to $31 on Pfizer on Pipeline Potential in Second Half of 2013,  Pfizer Latest News